|
Barbara J. Carter is an associate at Bromberg & Sunstein. She specializes in patent prosecution and the development and management of patent portfolios in the fields of chemistry, biochemistry, pharmaceuticals and related areas. In her practice, she advises her clients regarding infringement, freedom to operate and validity issues, licensing of technology and the development of licensing programs. She also actively participates in patent infringement suits especially in developing the key patent and technical strategies. Experience Barbara’s patent prosecution work has ranged from technology relating to stem cells to compounds used in MRI imaging; from catalytic hydroformylation and acid-catalyzed reactions to small molecule anticancer drugs and enzyme inhibitors; from ethanol production through fermentation to ethanol and syngas production through gasification of biomass; from natural products to radiosensitizers. Barbara advises on license agreements and licensing programs, performs due diligence and prepares freedom to operate and related opinions, and advises clients on their IP portfolio management. Barbara has participated in litigation between major pharmaceutical corporations regarding recombinant protein products, providing strategic advice and preparing expert reports, claims analysis, and defenses to infringement charges. Barbara has a Bachelor of Science in Chemistry, a Ph.D. in Bioorganic Chemistry, and post-doctoral research experience in a Supramolecular Chemistry laboratory under a Nobel Laureate. Prior to her career in law, Barbara was an Assistant Professor of Chemistry at the University of Toledo, in Ohio, where she taught chemistry, biochemistry and nucleic acid chemistry courses in the chemistry department for seven years at both the undergraduate and graduate levels. While in law school, Barbara worked in the Technology Transfer Office and managed, in an interim capacity, the University of Toledo’s extensive patent portfolio, assisting with licensing issues, prosecution, filings, and government contracts for research. Professional and Community Involvement Barbara has been an invited speaker at several conferences on fixed-dose combination and/or drug repurposing, published on the Hatch-Waxman Act and the LabCorp v. Metabolite litigation, and organized and chaired the 2007 and 2008 Massachusetts Continuing Legal Education Seminars on Current Trends in Biotech Law and Practice. | 